American Heart Association

07/15/2026 | Press release | Distributed by Public on 07/15/2026 03:09

Are survival rates for adults with congenital heart disease linked to specialized cardiac care access

Are survival rates for adults with congenital heart disease linked to specialized cardiac care access?

People with congenital heart disease living in states with lower average household incomes and higher percentages of uninsured residents had increased rates of death and disability, according to a new study in the Journal of the American Heart Association

Research Highlights:

  • In an analysis of the Global Burden of Disease Study compared with U.S. Census data from 1990-2021, researchers found that people with congenital heart disease living in states with lower average household incomes and fewer people with health insurance had higher rates of death and disability.
  • The research authors hypothesize that this difference may be due to easier access to specialized care and treatment from adult congenital heart disease cardiologists in communities with higher income levels and more residents with health insurance. Congenital heart disease requires lifelong, regular access to specialized cardiac care.
  • Expanding access to expert care, particularly in under-resourced regions of the U.S., could play a profound role in improving survival and quality of life for adult congenital heart disease patients.

Embargoed until 4 a.m. CT/5 a.m. ET Wed., July 15, 2026

DALLAS, July 15, 2026 - People with congenital heart disease living in states with low household incomes and limited access to health insurance and the specialized care they need may be more likely to become disabled or die from congenital heart disease, according to new, independent research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

Over the past 30 years, more children with congenital heart disease have survived into adulthood due to better surgical and catheter-based treatments, as well as improvements in medical care. As these children grow into adults, they continue to require specialized cardiac care, as recommended by evidence-based American Heart Association/American College of Cardiology guidelines, to maintain lifelong health and well-being.

This is one of the first studies to examine the connection between the health and survival of adults with congenital heart disease based on state-level data from the Global Burden of Disease Study along with income and insurance data from the U.S. Census, spanning from 1990 to 2021. Researchers examined the relationship among income levels, disability and death rates for nearly 300,000 adults with congenital heart disease aged 20 years and older.

"Understanding how social and economic factors can influence survival and outcomes is essential. Long-term outcomes and quality of life depend heavily on access to specialized, lifelong care for people with congenital heart disease," said senior author Anitha John, M.D., Ph.D., medical director of the Washington Adult Congenital Heart Program at Children's National in Washington, D.C. "Seeing how these factors affect patients long term allows us to better identify people at highest risk for complications. Then we can work toward improving access and reducing care gaps for people who have congenital heart disease."

What are the key findings of the analysis?

  • As median household income increased in a state, the death rate for people with congenital heart disease decreased.
  • The relationship between death rate and individual income levels was stronger than the connection between death rates and the percentage of residents without insurance in each state. This suggests that simply having health insurance did not guarantee that people accessed the specialized care required for congenital heart disease. One reason for this might be differences in types of insurance coverage versus the overall presence of insurance.
  • Geography and access to resources (namely, specialized cardiac care) likely play a profound role in death and disability in adults with congenital heart disease in the U.S. More research is needed to understand these connections and their impact on the health, well-being and survival of people with congenital heart disease.

"While having health insurance does matter, it does not explain the differences we found in terms of how long people with congenital heart disease live," John said. "This indicates that insurance alone doesn't guarantee access to care. People may still face barriers if their insurance doesn't cover specialized heart care or if out-of-pocket costs are too high. In many cases, specialized care may not be available in their area at all. We need to make sure everyone with congenital heart disease has the same access to specialty care throughout their lifetime, regardless of where they live."

"We also need more trained specialists in adult congenital heart conditions. These medical experts should be more evenly distributed across the country, particularly where congenital heart disease patients live and work. Additionally, we need better systems to help patients get referred to the right care throughout their lives," she said. "Expanding telehealth and improving insurance networks may also help to improve access."

Michelle Gurvitz, M.D., an American Heart Association volunteer expert and chair of the writing committee for the 2025 ACC/AHA/HRS/ISACHD/SCAI joint Guideline for the Management of Adults With Congenital Heart Disease, said, "The 2025 guideline outlines when to seek expert assistance and how specialists can work together with other healthcare providers to enhance access to care. Many patients stop receiving specialized care when they transition from pediatric to adult care. Additionally, this study shows that some patients cannot see specialists because of issues such as insurance or their location." Gurvitz, who was not involved in this study, is also a cardiologist at Boston Children's Hospital and an associate professor of pediatrics at Harvard Medical School.

According to the American Heart Association's 2026 Heart Disease and Stroke Statistics, congenital heart defects (heart or blood vessel issues that are present at birth) are one of the most common birth defects around the world. Congenital heart disease is the leading cause of death in the U.S. from a condition present since birth.

What are the study details, background, design and limitations?

  • Researchers reviewed data on death rates and "disability-adjusted life years" - the number of healthy life years lost due to a condition.
  • Income levels, including household income and insurance status (considered uninsured if they lacked coverage for a full year), detailed by state were secured from the U.S. Census Bureau data.
  • The findings show associations among the data points such as income, but cannot be interpreted as cause and effect. The associations found in the analysis may be influenced by factors like access to care, which the researchers could not directly measure.

Co-authors, disclosures and funding sources are listed in the manuscript.

Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries and AHA Expert Perspective: 214-706-1173

Karen Astle: [email protected]

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

American Heart Association published this content on July 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 15, 2026 at 09:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]